Hard to Treat Diseases (HTDS)

[abracky]

From what I see HTDS holds the patents (marketing rights).

Operating out of Delray Beach, Florida, Hard to Treat Diseases
Incorporated ("HTTD") holds the international marketing rights, except South
Korea, to Tubercin(R), a patented immunostimulant developed for combating
Cancer under medical patent (US Patent 6,274,356). The unique properties
unlike other cancer products are clearly stated in the abstract summary of
the patent... "A carbohydrate complex, which is a mixture of low
molecular-weight polysaccharides of an arabinomannan structure extracted
from Mycobacterium tuberculosis, is highly effective in treating various
cancer patients without incurring any adverse side effects."





ArTec Inc.,
Excutive Summary
"Tubercin"

WHAT IS TUBERCIN?

The United States Patent issued on August 14, 2001, states in the abstract the following: "A carbohydrate complex, which is a mixture of low molecular-weight poly saccharides of an arabinomannan structure extrated from Mycobacterium tuberculosis, is highly effective in treating various cancer patients without incurring any adverse side effects." For further informattion, the US Patent and Trademark Office's Official website is http://patft.uspto.gov/netacgi/tubercin.

Presently, Tubercin has been issued patents, not pending, in the following countries,

The Korean patent was issued on October 29, 1998 (Registration No. 173362).
The Japanese patent was issued on June 12, 1998 (Registration No. 2790447).
The United States patent was issued on August 14, 2001 (Registration No. 6,274,356).
The European patent was issued on August 13, 2003 (Registration No. 0991773).
The Canada patent was issued on May 11, 2004 (Registration No. 2,293,821)